133773-29-2

Basic information

• Product Name: (R)-1-(2,4-DICHLOROPHENYL)ETHANAMINE
• Synonyms: (R)-1-(2,4-DICHLOROPHENYL)ETHANAMINE;(1R)-1-(2,4-DICHLOROPHENYL)ETHAN-1-AMINE;(R)-1-(2,4-chlorophenyl)ethanaMine;(R)-1-(2,4-dichlorophenyl)ethan-1-amine;(1R)-1-(2,4-Dichlorophenyl)ethanamine Hydrochloride;(1R)-1-(2,4-dichlorophenyl)ethylamine;EOS-60919
• CAS NO: 133773-29-2
• Molecular Formula: C₈H₉Cl₂N
• Molecular Weight: 190.07
• Mol File: 133773-29-2.mol
• Article Data: 4

Chemical Properties

• Boiling Point: 256.4±25.0 °C(Predicted)
• Appearance: /
• Density: 1.262±0.06 g/cm3(Predicted)
• Storage Temp.: Keep in dark place,Inert atmosphere,Room temperature
• PKA: 8.28±0.10(Predicted)
• CAS DataBase Reference: (R)-1-(2,4-DICHLOROPHENYL)ETHANAMINE(CAS DataBase Reference)
• NIST Chemistry Reference: (R)-1-(2,4-DICHLOROPHENYL)ETHANAMINE(133773-29-2)
• EPA Substance Registry System: (R)-1-(2,4-DICHLOROPHENYL)ETHANAMINE(133773-29-2)

Safety Data

• Hazardous Substances Data: 133773-29-2(Hazardous Substances Data)

Usage

General Description

(R)-1-(2,4-Dichlorophenyl)ethanamine is a chemical compound with the molecular formula C8H10Cl2N. It is a chiral amine with a 2,4-dichlorophenyl group attached to the nitrogen atom. (R)-1-(2,4-DICHLOROPHENYL)ETHANAMINE has a wide range of potential applications, including as a building block in the synthesis of pharmaceuticals and other organic compounds. It may also have biological activity, given its structural similarity to other biologically active amines. As a result, (R)-1-(2,4-Dichlorophenyl)ethanamine is of interest to researchers in both the chemical and biological sciences and may have potential uses in the development of new drugs or other products.

Upstream product

• 89981-75-9 1-(2',4'-dichlorophenyl)ethylamine 

Downstream Products

• 323179-27-7 (R)-N-(4-phenylbenzyl)-2,4-dichloro-α-methylbenzylamine 
• 1260633-70-2 (R)-1-(2,4-dichlorophenyl)ethylammonium (S)-2-hydroxy-3-methoxy-3,3-diphenylpropionate 
• 1442445-21-7 (R)-5-bromo-N-(1-(2,4-dichlorophenyl)ethyl)-2-nitroaniline 
• 1442445-60-4 (R)-tert-butyl 4-(3-((R)-1-(2,4-dichlorophenyl)ethylamino)-4-nitrophenyl)-2-methylpiperazine-1-carboxylate 
• 1442445-61-5 N-((R)-1-(2,4-dichlorophenyl)ethyl)-5-((R)-3-methylpiperazin-1-yl)benzene-1,2-diamine 
• 1442445-62-6 1-((R)-1-(2,4-dichlorophenyl)ethyl)-6-((R)-3-methylpiperazin-1-yl)-1H-benzo[d][1,2,3]triazole 
• 1442445-63-7 (R)-tert-butyl 2-((R)-4-(1-((R)-1-(2,4-dichlorophenyl)ethyl)-1H-benzo[d][1,2,3]triazol-6-yl)-2-methylpiperazine-1-carbonyl)pyrrolidine-1-carboxylate 
• 1442445-15-9 ((R)-4-(1-((R)-1-(2,4-dichlorophenyl)ethyl)-1H-benzo[d][1,2,3]triazol-6-yl)-2-methylpiperazin-1-yl)((R)-pyrrolidin-2-yl)methanone 
• 1442445-68-2 (S)-tert-butyl 4-(4-amino-3-((R)-1-(2,4-dichlorophenyl)ethylamino)phenyl)-2-(hydroxymethyl)piperazine-1-carboxylate 
• 1442445-69-3 (S)-tert-butyl 4-(1-((R)-1-(2,4-dichlorophenyl)ethyl)-1H-benzo[d][1,2,3]triazol-6-yl)-2-(hydroxymethyl)piperazine-1-carboxylate 
• 1442445-70-6 ((S)-4-(1-((R)-1-(2,4-dichlorophenyl)ethyl)-1H-benzo[d][1,2,3]triazol-6-yl)piperazin-2-yl)methanol 
• 1442445-71-7 (R)-tert-butyl 2-((S)-4-(1-((R)-1-(2,4-dichlorophenyl)ethyl)-1H-benzo[d][1,2,3 ]triazol-6-yl)-2-(hydroxymethyl)piperazine-1-carbonyl)pyrrolidine-1-carboxylate 
• 1442445-17-1 ((S)-4-(1-((R)-1-(2,4-dichlorophenyl)ethyl)-1H-benzo[d][1,2,3]triazol-6-yl)-2-(hydroxymethyl)piperazin-1-yl)((R)-pyrrolidin-2-yl)methanone 
• 1442445-23-9 (R)-tert-butyl 4-(1-(1-(2,4-dichlorophenyl)ethyl)-1H-benzo[d]imidazol-6-yl)-5,6-dihydropyridine-1(2H)-carboxylate 

Relevant articles and documents

SUBSTITUTED BENZIMIDAZOLES AND BENZOPYRAZOLES AS CCR(4) ANTAGONISTS

Benzimidazole, benzopyrazole and benzotriazole compounds are provided which bind to CCR(4) and are useful for the treatment of diseases such as allergic diseases, autoimmune diseases, graft rejection and cancer.

COMPOSITIONS AND METHODS FOR CYCLOFRUCTANS AS SEPARATION AGENTS

The present invention relates to derivatized cyclofructan compounds, compositions comprising derivatized cyclofructan compounds, and methods of using compositions comprising derivatized cyclofructan compounds for chromatographic separations of chemical species, including enantiomers. Said compositions may comprise a solid support and/or polymers comprising derivatized cyclofructan compounds.